The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.
Open accessAbstract
Three independent variants with a profound reduction of cell surface H-2 have been selected from the C57BL/6 mouse-derived RBL-5 and EL-4 T lymphomas. After subcutaneous inoculation of low cell doses in syngeneic mice, the H-2- variants failed to grow out, whereas the H-2+ control lines showed progressive growth. No difference in growth rate or cloning efficiency was detectable in tissue culture. The in vivo difference in tumor outgrowth was analyzed in detail for one of the H-2-low lines. The outgrowth difference remained after the H-2-low variant and the control line had been injected subcutaneously in opposite flanks of the same mouse, and it was not dependent upon activity of mature T cells, since the same result was seen in athymic nude mice. The difference was partially sensitive to irradiation of the hosts. When mice were pretreated with anti-asialo GM1 antiserum, known to depress natural killer (NK) cell activity, the difference in outgrowth was abolished, and both the control line and the H-2- variant showed progressive growth in vivo. Experiments comparing the distribution and survival of isotope-prelabeled variant and wild type cells indicated that a rapid elimination of the former took place within 24 h after intravenous injection. These differences in tumor elimination were not seen in mice treated with anti-asialo GM1 antiserum. We conclude that the reduced tumorigenicity of sublines with impaired H-2 expression is largely, if not exclusively due to rapid elimination by NK cells. These findings may reflect an inverse, indirect relation between factors controlling H-2 expression and NK sensitivity. Another possible explanation is that major histocompatibility complex (MHC)-encoded gene products are directly involved in a regulatory signal in the NK cell system. According to this interpretation, immunological selectivity in the NK cell system would be achieved by the failure to recognize self-MHC, irrespective of the presence of foreign antigens, i.e. by detection of no-self rather than of nonself. This may also explain previous observations on H-2-linked hybrid resistance against lymphoid grafts and changes in H-2 phenotypes associated with tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ozato, K., & Sachs, D. H. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.1.317 · Cited by 571
Schrier, P. I., Bernards, R., Vaessen, R. T. M. J., Houweling, A., & van der Eb, A. J. (1983) · Nature · doi:10.1038/305771a0 · Cited by 559
Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumura, K., & Tamaoki, N. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.1.34 · Cited by 426
Wallich, R., Bulbuc, N., Hämmerling, G. J., Katzav, S., Segal, S., & Feldman, M. (1985) · Nature · doi:10.1038/315301a0 · Cited by 402
Reversal of Oncogenesis by the Expression of a Major Histocompatibility Complex Class I Gene
Tanaka, K., Isselbacher, K. J., Khoury, G., & Jay, G. (1985) · Science · doi:10.1126/science.3975631 · Cited by 366
Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation
Hui, K., Grosveld, F., & Festenstein, H. (1984) · Nature · doi:10.1038/311750a0 · Cited by 341
PECULIAR IMMUNOBIOLOGY OF BONE MARROW ALLOGRAFTS
Cudkowicz, G., & Bennett, M. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.6.1513 · Cited by 340
Do Natural Killer Cells Engage in Regulated Reactions Against Self to Ensure Homeostasis?
Cudkowicz, G., & Hochman, P. S. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00266.x · Cited by 306
Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens
Evans, G. A., Margulies, D. H., Shykind, B., Seidman, J. G., & Ozato, K. (1982) · Nature · doi:10.1038/300755a0 · Cited by 220
Primary structure of a murine transplantation antigen
Coligan, J. E., Kindt, T. J., Uehara, H., Martinko, J., & Nathenson, S. G. (1981) · Nature · doi:10.1038/291035a0 · Cited by 192
Cited by
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Self-citationRole of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,970
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Oncolytic viruses: a new class of immunotherapy drugs
Kaufman, H. L., Kohlhapp, F. J., & Zloza, A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4663 · Cited by 1,642
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., & Münz, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011149 · Cited by 994
Association of class I major histocompatibility heavy and light chains induced by viral peptides
Townsend, A., Öhlén, C., Bastin, J., Ljunggren, H.-G., Foster, L., & Kärre, K. (1989) · Nature · doi:10.1038/340443a0 · Cited by 985
Self-citationREGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Empty MHC class I molecules come out in the cold
Ljunggren, H.-G., Stam, N. J., Öhlén, C., Neefjes, J. J., Höglund, P., Heemels, M.-T., Bastin, J., Schumacher, T. N. M., Townsend, A., Kärre, K., et al. (1990) · Nature · doi:10.1038/346476a0 · Cited by 926
Self-citationDendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
Boczkowski, D., Nair, S. K., Snyder, D., & Gilboa, E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.465 · Cited by 915
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80426-4 · Cited by 762
Does the Immune System See Tumors as Foreign or Self?
Pardoll, D. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141135 · Cited by 753
New aspects of natural-killer-cell surveillance and therapy of cancer
Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc928 · Cited by 752
Kaer, L. V., Ashton-Rickardt, P. G., Ploegh, H. L., & Tonegawa, S. (1992) · Cell · doi:10.1016/s0092-8674(05)80068-6 · Cited by 724
Mechanisms of Immune Evasion by Tumors
Drake, C. G., Jaffee, E., & Pardoll, D. M. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90002-9 · Cited by 688
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
Porgador, A., Yewdell, J. W., Deng, Y., Bennink, J. R., & Germain, R. N. (1997) · Immunity · doi:10.1016/s1074-7613(00)80447-1 · Cited by 669
Evidence for a differential avidity model of T cell selection in the thymus
Ashton-Rickardt, P. G., Bandeira, A., Delaney, J. R., Van Kaer, L., Pircher, H.-P., Zinkernagel, R. M., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90505-3 · Cited by 668
Calcinotto, A., Filipazzi, P., Grioni, M., Iero, M., De Milito, A., Ricupito, A., Cova, A., Canese, R., Jachetti, E., Rossetti, M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1272 · Cited by 640
“B16F1 melanoma (American Type Culture Collection; ATCC) and RMA thymoma cells (18) were maintained in RPMI-1640 plus 10% heat-inactivated fetal calf serum (FCS).”
MethodNK cell-based immunotherapy for malignant diseases
Cheng, M., Chen, Y., Xiao, W., Sun, R., & Tian, Z. (2013) · Cellular & Molecular Immunology · doi:10.1038/cmi.2013.10 · Cited by 631
Ossendorp, F., Mengedé, E., Camps, M., Filius, R., & Melief, C. J. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.693 · Cited by 610
Prospects for the use of NK cells in immunotherapy of human cancer
Ljunggren, H.-G., & Malmberg, K.-J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2073 · Cited by 543
Self-citationRegulation of the Natural Killer Cell Receptor Repertoire
Raulet, D. H., Vance, R. E., & McMahon, C. W. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.291 · Cited by 521
Assembly of MHC class I molecules analyzed in vitro
Townsend, A., Elliott, T., Cerundolo, V., Foster, L., Barber, B., & Tse, A. (1990) · Cell · doi:10.1016/0092-8674(90)90366-m · Cited by 485
Natural killer cells as an initial defense against pathogens
Lodoen, M. B., & Lanier, L. L. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.05.002 · Cited by 472
Daëron, M., Latour, S., Malbec, O., Espinosa, E., Pina, P., Pasmans, S., & Fridman, W. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90134-5 · Cited by 451
Jandus, C., Boligan, K. F., Chijioke, O., Liu, H., Dahlhaus, M., Démoulins, T., Schneider, C., Wehrli, M., Hunger, R. E., Baerlocher, G. M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci65899 · Cited by 439
Natural Killer Cells and Cancer
(2003) · Advances in Cancer Research · doi:10.1016/s0065-230x(03)90004-2 · Cited by 438
Curnis, F., Sacchi, A., Borgna, L., Magni, F., Gasparri, A., & Corti, A. (2000) · Nature Biotechnology · doi:10.1038/81183 · Cited by 419
Interplay of natural killer cells and their receptors with the adaptive immune response
Raulet, D. H. (2004) · Nature Immunology · doi:10.1038/ni1114 · Cited by 413
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro
Schumacher, T. N. M., Heemels, M.-T., Neefjes, J. J., Kast, W. M., Melief, C. J. M., & Ploegh, H. L. (1990) · Cell · doi:10.1016/0092-8674(90)90020-f · Cited by 410
Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
Calarota, S., Bratt, G., Nordlund, S., Hinkula, J., Leandersson, A.-C., Sandström, E., & Wahren, B. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09440-3 · Cited by 400
Recognition of Tumors by the Innate Immune System and Natural Killer Cells
Marcus, A., Gowen, B. G., Thompson, T. W., Iannello, A., Ardolino, M., Deng, W., Wang, L., Shifrin, N., & Raulet, D. H. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00003-1 · Cited by 394
Reprogramming of T Cells to Natural Killer–Like Cells upon Bcl11b Deletion
Li, P., Burke, S., Wang, J., Chen, X., Ortiz, M., Lee, S.-C., Lu, D., Campos, L., Goulding, D., Ng, B. L., et al. (2010) · Science · doi:10.1126/science.1188063 · Cited by 374
TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective
Shepherd, J. C., Schumacher, T. N. M., Ashton-Rickardt, P. G., Imaeda, S., Ploegh, H. L., Janeway, C. A., & Tonegawa, S. (1993) · Cell · doi:10.1016/0092-8674(93)80058-m · Cited by 368
Development of human T and natural killer cells
Spits, H., Lanier, L., & Phillips, J. (1995) · Blood · doi:10.1182/blood.v85.10.2654.bloodjournal85102654 · Cited by 362
Yewdell, J. W., & Bennink, J. R. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60875-5 · Cited by 361
Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection
Kelly, J. M., Darcy, P. K., Markby, J. L., Godfrey, D. I., Takeda, K., Yagita, H., & Smyth, M. J. (2002) · Nature Immunology · doi:10.1038/ni746 · Cited by 356
NK Cell-Based Immune Checkpoint Inhibition
Khan, M., Arooj, S., & Wang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00167 · Cited by 356
Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C., & Moretta, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00943.x · Cited by 350
NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
Litwin, V, Gumperz, J., Parham, P., Phillips, J. H., & Lanier, L. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.537 · Cited by 348
Natarajan, K., Dimasi, N., Wang, J., Mariuzza, R. A., & Margulies, D. H. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064812 · Cited by 335
Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Charrier, S., Ryffel, B., Cambi, A., Figdor, C., Vainchenker, W., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0380 · Cited by 326
NK Cells, MHC Class I Molecules and the Missing Self
Kärre, K. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01053.x · Cited by 325
Self-citationEradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes
Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A. C., Meloen, R. H., van der Eb, A. J., & Melief, C. J. M. (1989) · Cell · doi:10.1016/0092-8674(89)90006-8 · Cited by 301
Natural killer cell-mediated immunosurveillance of human cancer
Malmberg, K.-J., Carlsten, M., Björklund, A., Sohlberg, E., Bryceson, Y. T., & Ljunggren, H.-G. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.002 · Cited by 299
Self-citationNatural killer cell recognition of missing self
Kärre, K. (2008) · Nature Immunology · doi:10.1038/ni0508-477 · Cited by 296
Self-citationPerforin Is a Major Contributor to NK Cell Control of Tumor Metastasis
Smyth, M. J., Thia, K. Y. T., Cretney, E., Kelly, J. M., Snook, M. B., Forbes, C. A., & Scalzo, A. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6658 · Cited by 295
Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E., & Raulet, D. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803900 · Cited by 291
Delivery of Epitopes by the Salmonella Type III Secretion System for Vaccine Development
Rüssmann, H., Shams, H., Poblete, F., Fu, Y., Galán, J. E., & Donis, R. O. (1998) · Science · doi:10.1126/science.281.5376.565 · Cited by 276
Lodoen, M., Ogasawara, K., Hamerman, J. A., Arase, H., Houchins, J. P., Mocarski, E. S., & Lanier, L. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021973 · Cited by 275
Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice
Borvak, J. (1998) · International Immunology · doi:10.1093/intimm/10.9.1289 · Cited by 254
Metadata
- Authors
- Ljunggren, H. G., & Kärre, K.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1985-12-01
- Volume
- 162
- Issue
- 6
- Pages
- 1745-1759
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2118376550
- Cited by
- 736
- References
- 19
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.